Actively Recruiting
Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
Led by Peking University Third Hospital · Updated on 2025-05-01
330
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.
CONDITIONS
Official Title
Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3)
- Confirmation of patent foramen ovale through transthoracic echocardiography (TTE) or transesophageal echocardiography (TEE)/right heart contrast echocardiography
- Agree to participate in the study and sign the informed consent form
You will not qualify if you...
- Cannot sign the informed consent form or cooperate with follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Third Hospital
Beijing, China
Actively Recruiting
Research Team
Y
Yu Fu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here